Boehringer Ingelheim Opens $31.5 Million Oncology Antibody-Drug Conjugate Facility in Switzerland Image Credit: Adobe Stock Images/MichaelVi Boehringer Ingelheim announced the official opening of a new antibody-drug conjugate (ADC) research and development…
Hubs East 2025: Building a Thriving Culture In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how…
Expanding Pharmacies’ Scope of Practice In the full video interview with Pharma Commerce, Jenni Zilka, SVP, community & specialty pharmacy and president, Good Neighbor Pharmacy, noted…